Micromedic Technologies (Israel) Financial Indicators Patterns

MCTC -- Israel Stock  

ILS 58.10  1.40  2.35%

Use fundamental data analysis to check out all available financial ratios of Micromedic Technologies to find out if markets are presently mispricing the entity. We found twenty-nine available fundamentals for Micromedic Technologies which can be compared to its peers in the industry. To make sure the equity is not overpriced, please verify all Micromedic Technologies Ltd fundamentals including its Shares Outstanding, Price to Book, Revenue, as well as the relationship between Price to Earning and Price to Sales . Use Micromedic Technologies to protect your portfolios against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals. Check odds of Micromedic Technologies to be traded at S55.78 in 30 days.
47%

Chance of Financial Distress

Micromedic Technologies Ltd has less than 47 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Micromedic Technologies Company Summary

Micromedic Technologies Ltd. engages in the development and commercialization of in vitro cancer diagnostic products and solutions in Israel. In addition, it offers gene expression, and biomarker and histochemical assays for early cancer detection and personalized medicine. Micromedic Technologies operates under Diagnostics Research classification in Israel and is traded on Tel Aviv Stock Exchange.

Micromedic Technologies EBITDA vs Return On Equity

Micromedic Technologies Ltd is considered to be number one stock in ebitda category among related companies. It is considered to be number one stock in return on equity category among related companies .

Micromedic Technologies Market Fundamentals

 Quote58.10
 Change(%) 2.35%
 Change1.40 
 Open59.5
 Low58.1
 High58.1
 Volume1.000
 ExchangeTLV

Micromedic Technologies April 22, 2019 Opportunity Range

Please see also Stocks Correlation. Please also try Chance of Distress module to get analysis of equity chance of financial distress in the next 2 years.
Search macroaxis.com